Both in Pharmaceuticals
Tilray Brands vs Altimmune
Over the past year TLRY returned −79.8% and ALT returned −48.5%; their daily moves had a correlation of 0.22.
TLRY −79.8% ALT −48.5%Growth of $1, one year, split-adjusted
| Metric | TLRY | ALT |
|---|---|---|
| Price | $2.65 | $2.04 |
| Market cap | $391.6M | $396.8M |
| Today | +3.92% | +0.99% |
| 1 month | −28.8% | −23.6% |
| 6 months | −53.4% | −33.3% |
| Year to date | −70.7% | −43.5% |
| 1 year | −80.2% | −49.6% |
| Revenue growth (YoY) | +22.7% | −100.0% |
| Gross margin | 30.1% | — |
| Net margin | −16.8% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 12,800.5× |
| Net cash | $16.6M | $291.5M |
| Dividend yield | — | — |
| Volatility (60d) | 47.3% | 47.0% |
| Short % of float | 14.6% | 22.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).